Shaily Engineering Plastics — Professional Company Profile
Shaily Engineering Plastics Limited — Company Overview
Shaily Engineering Plastics Limited (SEPL) is an India-based, publicly listed precision plastics engineering and manufacturing company with a strong export orientation. Established in 1987, the company has evolved from a small injection-moulding operation into one of India's leading exporters of engineered plastic components, serving global customers across healthcare, consumer products, beauty and personal care, lighting, appliances and automotive applications. (shaily.com)
The company operates primarily from manufacturing facilities in Gujarat, supported by a global presence and more than 2,000 employees. Its manufacturing infrastructure includes approximately 210 injection-moulding machines, ranging from 35 tonnes to 1,200 tonnes, supported by automation, robotics, precision tooling and sophisticated quality-control systems. (shaily.com)
Business Model
Shaily's competitive positioning is based on providing high-precision, high-quality plastic components rather than commodity plastic products. Its capabilities span the entire product-development and manufacturing chain:
Product design and engineering
Tool and mould manufacturing
Precision injection moulding
High-performance engineering polymers
Automated and semi-automated assembly
Secondary finishing operations
Metrology and quality assurance
Prototyping and new-product development
The company can manufacture highly complex components as small as 0.03 grams with tolerances of approximately 5 microns, demonstrating the level of precision required for demanding healthcare, medical-device and engineering applications.
Key Business Verticals
1. Healthcare and Drug Delivery
Healthcare has become an increasingly important growth engine for Shaily. The company manufactures precision components and devices for drug delivery and medical applications, operating to stringent standards including ISO 13485, ISO 15378 and MDSAP. Its capabilities position it to participate in the growing global market for sophisticated drug-delivery systems and medical devices. (shaily.com)
2. Consumer Products
Shaily supplies high-volume precision plastic products used in kitchen, cooking, eating, organisation and storage applications. The company has dedicated facilities and significant moulding capacity for global consumer-product customers. (shaily.com)
3. Beauty & Personal Care
The company manufactures precision plastic components and packaging for beauty and personal-care applications, where aesthetics, consistency, dimensional accuracy and high-volume production are important differentiators. (shaily.com)
4. Lighting, Appliances & Automotive
Shaily also manufactures engineering-plastic components for lighting, appliances and automotive applications. Its expertise in polymers such as PPS, PBT, LCP, PES, PEEK and Torlon, in addition to conventional engineering polymers, enables substitution of metal components with high-performance plastics in selected applications. (shaily.com)
Global Customer Base
A significant strength of Shaily is its relationships with large multinational customers. The company states that it is trusted by Fortune 100 companies and lists customers including IKEA, Procter & Gamble, Hindustan Unilever, Sanofi, Zydus, Dr. Reddy's, Aspen, ABB, Siemens, Honeywell and Garrett, among others. (shaily.com)
Its business is strongly export-oriented. In FY2024-25, approximately 78% of revenue was derived from exports, giving Shaily exposure to global customers and markets rather than being dependent solely on domestic demand. (static.shaily.com)
Financial Performance
Shaily has demonstrated strong financial growth in recent years. In FY2024-25, consolidated revenue reached approximately ₹786.8 crore, compared with ₹643.9 crore in FY2023-24, representing 22% year-on-year growth.
More importantly, profitability grew faster than revenue:
| FY2024-25 | Performance |
|---|---|
| Revenue | ₹786.8 crore |
| Revenue growth | 22% |
| EBITDA | ₹178.4 crore |
| EBITDA growth | 45% |
| EBITDA margin | 22.7% |
| PBT | ₹119.3 crore |
| PBT growth | 71% |
| PAT | ₹93.1 crore |
| PAT growth | 63% |
| Debt/Equity | 0.40x |
The improvement in EBITDA margin from approximately 19.2% to 22.7% indicates meaningful operating leverage and a favourable shift toward higher-value products. (static.shaily.com)
Competitive Advantages
Shaily's principal competitive advantages can be summarised as:
Engineering capability: Its combination of product design, mould making, precision moulding, automation and assembly provides an integrated manufacturing proposition.
High entry barriers: Medical and healthcare components require stringent regulatory approvals, quality systems and customer validation, making supplier replacement relatively difficult.
Global customer relationships: Long-standing relationships with multinational customers create opportunities for repeat business and new-product introductions.
Complexity rather than commodity: The company increasingly focuses on high-value engineering plastics and precision components, which can command better margins than conventional injection moulding.
Export capability: A large export base demonstrates its ability to meet international quality, regulatory, delivery and sustainability requirements.
Material expertise: Its processing capability extends into advanced polymers including PEEK, PPS, LCP, PES and Torlon. Shaily describes itself as the only licensed processor of Torlon in India. (shaily.com)
Growth Opportunity
The most significant structural opportunity for Shaily appears to be the transition from being a precision plastics component manufacturer toward becoming a higher-value integrated engineering and healthcare-products partner.
Healthcare and drug delivery are particularly attractive because they combine several favourable characteristics: increasing global demand, high regulatory barriers, product complexity, customer stickiness and relatively high value addition. Recent company disclosures indicate that healthcare-led growth has been an important driver of its financial performance. (shaily.com)
The company is also investing in additional pharmaceutical manufacturing capacity; FY2024-25 capex of approximately ₹72.2 crore included significant expenditure toward a new pharma plant. (static.shaily.com)
Overall Assessment
Shaily Engineering Plastics is best viewed not as a conventional plastic-moulding company, but as a precision engineering and contract manufacturing platform built around advanced polymers, moulding, automation and healthcare applications.
Its investment thesis rests on the combination of:
Global customers + high switching costs + engineering complexity + healthcare exposure + export orientation + improving margins.
The principal factors to monitor are customer concentration, execution of healthcare/pharma capacity expansion, capex intensity, working-capital requirements, export-market conditions and valuation. Given the strong earnings growth already achieved, the key question for investors is increasingly whether future growth can remain sufficiently high to justify the company's market valuation. (static.shaily.com)
In one sentence: Shaily is evolving from an Indian injection-moulding manufacturer into a globally integrated precision-engineering, medical-device and advanced-plastics platform, with healthcare emerging as its most important long-term growth driver.
Comments